Industry | 2017.11.01
Cutting-Edge Tumor Immunology and Cancer Immunotherapy Research Anticipated at Society for Immunotherapy of Cancer’s 32nd Annual Meeting
As approaches that engage the immune system continue to transform the standard of care in cancer treatment, leading experts in tumor immunology and cancer immunotherapy will gather to share cutting-edge basic and translational research, and emerging clinical data, at the Society for Immunotherapy of Cancer’s (SITC) 32nd Annual Meeting, Nov. 10-12, in National Harbor, Md.
(PRWeb November 01, 2017)
Read the full story at http://www.prweb.com/releases/2017/11/prweb14868996.htm
For more information, please visit
http://www.prweb.com/releases/2017/11/prweb14868996.htm
